The importance of the PI3K-AKT-mTOR pathway in the pathobiology of meningiomas is furthermore emphasized by the fact that chr 10q, harboring the PTEN gene, an inhibitor of this pathway, is frequently lost in high-grade NF2 mutant meningiomas. This evidence concerns the gene NF2 and meningioma.